Summary
A patient received 200 mg methotrexate IM as part of a treatment schedule for malignant melanoma. Severe vomiting and diarrhoea began shortly after treatment and persisted for 4 h. During this period the methotrexate renal clearance rate was 37 ml·min-1, increasing to 97 ml·min-1 when vomiting and diarrhoea ceased. Only 26% of the administered dose was recovered in the urine up to 48 h after treatment, whilst the plasma clearance of methotrxate assessed over the same period was 208 ml·min-1. We conclude that a considerable proportion of the dose was lost from the gastrointestinal tract during the period of vomiting and diarrhoea, and that consequently enterohepatic circulation of methotrexate plays an important role in the pharmacokinetics of the drug.
Similar content being viewed by others
References
Aherne GW, Piall E, Marks V, Mould G, White WF (1978) Prolongation and enhancement of serum methotrexate concentrations by probenecid. Br. Med J 1:1097
Calvert AH, Bondy PK, Harrap KR (1977) Some observations on the human pharmacology of methotrexate. Cancer Treat Rep 61:1647
Huffman DH, Wan SH, Azarnoff DL, Hoogstraten B (1973) Pharmacokinetics of methotrexate. Clin Pharmacol Ther 14:572
Leme PR, Creaven PJ, Allen LM, Berman M (1975) Kinetic model for the disposition and metabolism of moderate and high dose methotrexate in man. Cancer Chemother Rep 59:811
Raso V, Schreiber R (1975) A rapid and specific radioimmunoassay for methotrexate. Cancer Res 35:1407
Reich SD, Bachur NR, Goebel RH, Berman M (1977) Pharmacokinetic model for high dose methotrexate infusions in man. J Pharmacokin Biopharmacol 5:421
Strum WB, Liem HH (1977) Hepatic uptake, intracellular protein binding and biliary excretion of amethopterin. Biochem Pharmacol 26:1235
Wan SH, Huffman DH, Azarnoff DL, Stephens R, Hoogstraten B (1974) Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res 34:3487
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Den Berg, H.W., Murphy, R.F. & Kennedy, D.G. Rapid plasma clearance and reduced rate and extent of urinary elimination of parenterally administered methotrexate as a result of severe vomiting and diarrhoea. Cancer Chemother. Pharmacol. 4, 47–48 (1980). https://doi.org/10.1007/BF00255458
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00255458